Nevro Price to Book Ratio 2013-2023 | NVRO

Historical price to book ratio values for Nevro (NVRO) over the last 10 years. The current price to book ratio for Nevro as of April 17, 2024 is 1.57.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Nevro Price/Book Ratio Historical Data
Date Stock Price Book Value per Share Price to Book Ratio
2024-04-17 12.29 1.52
2023-12-31 21.52 $8.06 2.67
2023-09-30 19.22 $7.89 2.43
2023-06-30 25.42 $8.17 3.11
2023-03-31 36.15 $8.44 4.28
2022-12-31 39.60 $9.12 4.34
2022-09-30 46.60 $9.17 5.08
2022-06-30 43.83 $6.50 6.74
2022-03-31 72.33 $6.83 10.59
2021-12-31 81.07 $8.67 9.35
2021-09-30 116.38 $9.15 12.72
2021-06-30 165.79 $10.28 16.12
2021-03-31 139.50 $10.56 13.22
2020-12-31 173.10 $11.23 15.41
2020-09-30 139.30 $11.03 12.62
2020-06-30 119.47 $10.92 10.94
2020-03-31 99.98 $6.72 14.89
2019-12-31 117.54 $6.86 17.14
2019-03-31 62.51 $7.03 8.89
2018-12-31 38.89 $8.11 4.79
2018-09-30 57.00 $8.10 7.03
2018-06-30 79.85 $8.16 9.78
2018-03-31 86.67 $8.10 10.70
2017-12-31 69.04 $8.38 8.24
2017-09-30 90.88 $8.25 11.02
2017-06-30 74.43 $8.18 9.10
2017-03-31 93.70 $8.29 11.31
2016-12-31 72.66 $8.62 8.43
2016-09-30 104.39 $8.66 12.06
2016-06-30 73.76 $8.65 8.53
2015-12-31 67.51 $8.34 8.10
2015-09-30 46.39 $8.75 5.30
2015-06-30 53.75 $9.41 5.71
2015-03-31 47.93 $6.39 7.50
2014-12-31 38.67 $6.92 5.59
2019-09-30 85.97 $6.39 13.45
2019-06-30 64.83 $6.53 9.93
2016-03-31 56.26 $8.08 6.96
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.466B $0.425B
Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $211.679B 25.75
Intuitive Surgical (ISRG) United States $134.177B 83.75
Edwards Lifesciences (EW) United States $54.204B 35.88
DexCom (DXCM) United States $52.631B 90.41
IQVIA Holdings (IQV) United States $41.589B 24.67
IDEXX Laboratories (IDXX) United States $40.661B 48.62
Alcon (ALC) Switzerland $39.256B 28.95
STERIS (STE) Ireland $19.665B 23.28
Waters (WAT) United States $18.607B 26.70
Hologic (HOLX) United States $17.631B 19.46
SONOVA HOLDING (SONVY) Switzerland $16.535B 0.00
ShockWave Medical (SWAV) United States $12.247B 84.62
Fresenius Medical Care AG KGaA (FMS) Germany $10.915B 13.48
Sysmex ADR (SSMXY) Japan $9.988B 31.32
Teleflex (TFX) United States $9.896B 15.54
Penumbra (PEN) United States $8.130B 100.50
Masimo (MASI) United States $7.312B 41.00
Globus Medical (GMED) United States $7.011B 22.23
Glaukos (GKOS) United States $4.796B 0.00
Integer Holdings (ITGR) United States $3.997B 25.55
TransMedics (TMDX) United States $3.052B 0.00
LivaNova (LIVN) United Kingdom $2.869B 18.92
Elekta AB (EKTAY) Sweden $2.673B 18.34
PROCEPT BioRobotics (PRCT) United States $2.650B 0.00
Integra LifeSciences Holdings (IART) United States $2.501B 10.27
Nihon Kohden (NHNKY) Japan $2.368B 20.03
Inari Medical (NARI) United States $2.266B 391.00
Tandem Diabetes Care (TNDM) United States $2.128B 0.00
RxSight (RXST) United States $2.009B 0.00
Alphatec Holdings (ATEC) United States $1.820B 0.00
Veracyte (VCYT) United States $1.420B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.862B 15.94
OPKO Health (OPK) United States $0.843B 0.00
Artivion (AORT) United States $0.837B 96.71
Paragon 28 (FNA) United States $0.799B 0.00
OrthoPediatrics (KIDS) United States $0.718B 0.00
Treace Medical Concepts (TMCI) United States $0.712B 0.00
Silk Road Medical (SILK) United States $0.694B 0.00
SiBone (SIBN) United States $0.630B 0.00
Mesa Laboratories (MLAB) United States $0.553B 18.77
IRadimed (IRMD) United States $0.520B 30.17
ORTHOFIX MEDICAL INC (OFIX) United States $0.493B 0.00
Pulse Biosciences (PLSE) United States $0.430B 0.00
Pacific Biosciences Of California (PACB) United States $0.375B 0.00
NeuroPace (NPCE) United States $0.369B 0.00
CVRx (CVRX) United States $0.354B 0.00
Tactile Systems Technology (TCMD) United States $0.342B 11.50
AxoGen (AXGN) United States $0.306B 0.00
EDAP TMS S.A (EDAP) France $0.271B 0.00
AngioDynamics (ANGO) United States $0.261B 0.00
Sight Sciences (SGHT) United States $0.259B 0.00
Accuray (ARAY) United States $0.221B 0.00
Atossa Genetics (ATOS) United States $0.193B 0.00
908 Devices (MASS) United States $0.191B 0.00
Alpha Tau Medical (DRTS) Israel $0.190B 0.00
Semler Scientific (SMLR) United States $0.183B 9.84
Inogen (INGN) United States $0.162B 0.00
ClearPoint Neuro (CLPT) United States $0.151B 0.00
Neuronetics (STIM) United States $0.121B 0.00
Delcath Systems (DCTH) United States $0.120B 0.00
Envoy Medical (COCH) United States $0.117B 0.00
Yubo Biotech (YBGJ) China $0.112B 0.00
KORU Medical Systems (KRMD) United States $0.098B 0.00
Spectral Diagnostics (EDTXF) Canada $0.090B 0.00
Monogram Orthopaedics (MGRM) United States $0.083B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
EnVVeno Medical (NVNO) United States $0.063B 0.00
SEP Acquisition (SEPA) United States $0.058B 0.00
Vasomedical (VASO) United States $0.057B 10.32
InspireMD (NSPR) Israel $0.053B 0.00
Sensus Healthcare (SRTS) United States $0.052B 106.67
Autonomix Medical (AMIX) United States $0.052B 0.00
Vicarious Surgical (RBOT) United States $0.052B 0.00
Aspira Women's Health (AWH) United States $0.043B 0.00
ReWalk Robotics (LFWD) Israel $0.042B 0.00
Rapid Micro Biosystems (RPID) United States $0.040B 0.00
Lucid Diagnostics (LUCD) United States $0.039B 0.00
Pixie Dust Technologies (PXDT) Japan $0.038B 0.00
Spectral AI (MDAI) United States $0.035B 0.00
DarioHealth (DRIO) United States $0.034B 0.00
LENSAR (LNSR) United States $0.034B 0.00
Precision Optics (POCI) United States $0.033B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.024B 0.00
QT Imaging Holdings (QTI) United States $0.018B 0.00
Accelerate Diagnostics (AXDX) United States $0.018B 0.00
PAVmed (PAVM) United States $0.017B 0.00
T2 Biosystems (TTOO) United States $0.017B 0.00
Microbot Medical (MBOT) United States $0.014B 0.00
Biosig Technologies (BSGM) United States $0.014B 0.00
NexGel (NXGL) United States $0.013B 0.00
Check-Cap (CHEK) Israel $0.013B 0.00
Avinger (AVGR) United States $0.006B 0.00
Venus Concept (VERO) Canada $0.005B 0.00
Helius Medical Technologies (HSDT) United States $0.005B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Tenon Medical (TNON) United States $0.003B 0.00
Dynatronics (DYNT) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
ReShape Lifesciences (RSLS) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00